$AVEO Recent News Aveo loss widens on revenue
Post# of 94268
Posted On: 08/04/2014 9:47:58 AM
$AVEO Recent News
Aveo loss widens on revenue drop; shares down 9:48 a.m. April 30, 2013 - MarketWatch.com
Updates, advisories and surprises 5:01 p.m. Aug. 2, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 1:11 p.m. Aug. 2, 2012 - MarketWatch
Aveo sinks 27% after FDA update, earnings 11:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Aveo dives 25% on FDA update 10:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Dividends don't lie 9:51 a.m. Jan. 9, 2012 - The Trading Deck
Aveo cancer treatment meets goal, but shares drop 3:43 p.m. Jan. 3, 2012 - MarketWatch.com
Aveo reports progress with cancer-drug candidate 7:58 a.m. Jan. 3, 2012 - MarketWatch.com
Updates, advisories and surprises 5:31 p.m. July 28, 2011 - MarketWatch
AVEO climbs on earnings, outlook 12:18 p.m. July 28, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:46 p.m. June 15, 2011 - Kate Gibson
Regeneron energizes biotech stocks 3:37 p.m. June 15, 2011 - Val Brickates Kennedy
AVEO shares tumble 10% on stock offer pricing 10:19 a.m. June 15, 2011 - Val Brickates Kennedy
Inspire, AVEO take lead in drug-stocks trading 4:14 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO shares jump on Astellas pact 12:04 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 6.4% - Tale of the Tape 9:18 a.m. July 1, 2014 - Zacks.com
Can the Uptrend Continue for AVEO Pharmaceuticals (AVEO)? - Tale of the Tape 9:42 a.m. June 26, 2014 - Zacks.com
AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% - Tale of the Tape 9:46 a.m. June 18, 2014 - Zacks.com
$5 Or Less: 3 Small, Speculative Biotechs On The Move 1:41 p.m. June 17, 2014 - Seeking Alpha
AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% - Tale of the Tape 8:44 a.m. June 10, 2014 - Zacks.com
PTC Therapeutics Up on Positive CHMP Opinion - Analyst Blog 3:22 p.m. May 27, 2014 - Zacks.com
Sarepta to Acquire Manufacturing Facility - Analyst Blog 4:45 p.m. May 23, 2014 - Zacks.com
Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update 4:18 a.m. May 15, 2014 - Seeking Alpha
Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment 12:58 p.m. May 9, 2014 - Seeking Alpha
Narrower-than-Expected Loss at AVEO - Analyst Blog 9:20 a.m. May 8, 2014 - Zacks.com
10-Q: AVEO PHARMACEUTICALS INC 4:16 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Market Just Isn't Convinced The AVEO Nightmare Is Over 12:20 p.m. May 1, 2014 - Seeking Alpha
AVEO-Biodesix Ink Deal - Analyst Blog 5:00 p.m. April 11, 2014 - Zacks.com
A ray of hope for ficlatuzumab 7:50 a.m. April 10, 2014 - Seeking Alpha
High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued 8:30 a.m. April 1, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape 9:39 a.m. March 24, 2014 - Zacks.com
AVEO Regains AV-203 Rights from Biogen - Analyst Blog 6:10 p.m. March 21, 2014 - Zacks.com
Aveo Regains Rights to Antibody 5:19 p.m. March 20, 2014 - The Wall Street Journal Interactive Edition
AVEO Q4 Loss Narrower than Expected - Analyst Blog 9:10 a.m. March 14, 2014 - Zacks.com
Conference Call Schedules, Acquisitions, and Public Offerings - Analyst Notes on Johnson & Johnson, Merck, GW, Endocyte and AVEO 6:10 a.m. June 20, 2014 - PR Newswire - PRF
AVEO Oncology Announces Presentation of AV-203 Phase 1 Results at 2014 American Society of Clinical Oncology Annual Meeting 2:21 p.m. May 31, 2014 - BusinessWire - BZX
Top Gainers Technical Data -- Research on Northwest Biotherapeutics, Midstates Petroleum, AVEO Pharma, and Infinity Pharma 8:21 a.m. May 12, 2014 - PR Newswire - PRF
AVEO Oncology Reports First Quarter 2014 Financial Results 4:16 p.m. May 7, 2014 - BusinessWire - BZX
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 5:40 p.m. May 5, 2014 - PR Newswire - PRF
AVEO Oncology to Report First Quarter 2014 Financial Results on May 7, 2014 8:37 a.m. May 5, 2014 - BusinessWire - BZX
AVEO and Biodesix Partner to Co-Develop and Commercialize Ficlatuzumab with a Companion Diagnostic for Treatment of NSCLC 6:31 a.m. April 10, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on Newfield Exploration, Endocyte, Columbia Property Trust, and AVEO Pharma 10:09 a.m. March 24, 2014 - PR Newswire - PRF
AVEO Regains Worldwide Rights to AV-203 4:31 p.m. March 20, 2014 - BusinessWire - BZX
Fate Therapeutics Appoints Dr. Robert S. Epstein to Its Board of Directors 7:41 a.m. March 17, 2014 - GlobeNewswire
AVEO Announces Timing for Conference Call to Discuss Year-End 2013 Financial Results and Provide Strategic Update for 2014 7:31 a.m. March 4, 2014 - BusinessWire - BZX
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and Commercialization of Tivozanib 6:31 a.m. Feb. 14, 2014 - BusinessWire - BZX
Catabasis Announces Appointment of Kenneth M. Bate as Independent Director 9:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
AVEO and Astellas Discontinue Phase 2 Trial of Tivozanib in Breast Cancer 7:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
AVEO Provides Update on Interim Analysis from Tivozanib Trial in Colorectal Cancer 7:50 a.m. Dec. 13, 2013 - BusinessWire
AVEO Reports Third Quarter 2013 Financial Results 7:32 a.m. Nov. 7, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 1:18 p.m. Sept. 4, 2013 - PR Newswire
AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Sept. 4, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 3:48 p.m. Aug. 28, 2013 - PR Newswire
Aveo loss widens on revenue drop; shares down 9:48 a.m. April 30, 2013 - MarketWatch.com
Updates, advisories and surprises 5:01 p.m. Aug. 2, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 1:11 p.m. Aug. 2, 2012 - MarketWatch
Aveo sinks 27% after FDA update, earnings 11:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Aveo dives 25% on FDA update 10:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Dividends don't lie 9:51 a.m. Jan. 9, 2012 - The Trading Deck
Aveo cancer treatment meets goal, but shares drop 3:43 p.m. Jan. 3, 2012 - MarketWatch.com
Aveo reports progress with cancer-drug candidate 7:58 a.m. Jan. 3, 2012 - MarketWatch.com
Updates, advisories and surprises 5:31 p.m. July 28, 2011 - MarketWatch
AVEO climbs on earnings, outlook 12:18 p.m. July 28, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:46 p.m. June 15, 2011 - Kate Gibson
Regeneron energizes biotech stocks 3:37 p.m. June 15, 2011 - Val Brickates Kennedy
AVEO shares tumble 10% on stock offer pricing 10:19 a.m. June 15, 2011 - Val Brickates Kennedy
Inspire, AVEO take lead in drug-stocks trading 4:14 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO shares jump on Astellas pact 12:04 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 6.4% - Tale of the Tape 9:18 a.m. July 1, 2014 - Zacks.com
Can the Uptrend Continue for AVEO Pharmaceuticals (AVEO)? - Tale of the Tape 9:42 a.m. June 26, 2014 - Zacks.com
AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% - Tale of the Tape 9:46 a.m. June 18, 2014 - Zacks.com
$5 Or Less: 3 Small, Speculative Biotechs On The Move 1:41 p.m. June 17, 2014 - Seeking Alpha
AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% - Tale of the Tape 8:44 a.m. June 10, 2014 - Zacks.com
PTC Therapeutics Up on Positive CHMP Opinion - Analyst Blog 3:22 p.m. May 27, 2014 - Zacks.com
Sarepta to Acquire Manufacturing Facility - Analyst Blog 4:45 p.m. May 23, 2014 - Zacks.com
Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update 4:18 a.m. May 15, 2014 - Seeking Alpha
Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment 12:58 p.m. May 9, 2014 - Seeking Alpha
Narrower-than-Expected Loss at AVEO - Analyst Blog 9:20 a.m. May 8, 2014 - Zacks.com
10-Q: AVEO PHARMACEUTICALS INC 4:16 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Market Just Isn't Convinced The AVEO Nightmare Is Over 12:20 p.m. May 1, 2014 - Seeking Alpha
AVEO-Biodesix Ink Deal - Analyst Blog 5:00 p.m. April 11, 2014 - Zacks.com
A ray of hope for ficlatuzumab 7:50 a.m. April 10, 2014 - Seeking Alpha
High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued 8:30 a.m. April 1, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape 9:39 a.m. March 24, 2014 - Zacks.com
AVEO Regains AV-203 Rights from Biogen - Analyst Blog 6:10 p.m. March 21, 2014 - Zacks.com
Aveo Regains Rights to Antibody 5:19 p.m. March 20, 2014 - The Wall Street Journal Interactive Edition
AVEO Q4 Loss Narrower than Expected - Analyst Blog 9:10 a.m. March 14, 2014 - Zacks.com
Conference Call Schedules, Acquisitions, and Public Offerings - Analyst Notes on Johnson & Johnson, Merck, GW, Endocyte and AVEO 6:10 a.m. June 20, 2014 - PR Newswire - PRF
AVEO Oncology Announces Presentation of AV-203 Phase 1 Results at 2014 American Society of Clinical Oncology Annual Meeting 2:21 p.m. May 31, 2014 - BusinessWire - BZX
Top Gainers Technical Data -- Research on Northwest Biotherapeutics, Midstates Petroleum, AVEO Pharma, and Infinity Pharma 8:21 a.m. May 12, 2014 - PR Newswire - PRF
AVEO Oncology Reports First Quarter 2014 Financial Results 4:16 p.m. May 7, 2014 - BusinessWire - BZX
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 5:40 p.m. May 5, 2014 - PR Newswire - PRF
AVEO Oncology to Report First Quarter 2014 Financial Results on May 7, 2014 8:37 a.m. May 5, 2014 - BusinessWire - BZX
AVEO and Biodesix Partner to Co-Develop and Commercialize Ficlatuzumab with a Companion Diagnostic for Treatment of NSCLC 6:31 a.m. April 10, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on Newfield Exploration, Endocyte, Columbia Property Trust, and AVEO Pharma 10:09 a.m. March 24, 2014 - PR Newswire - PRF
AVEO Regains Worldwide Rights to AV-203 4:31 p.m. March 20, 2014 - BusinessWire - BZX
Fate Therapeutics Appoints Dr. Robert S. Epstein to Its Board of Directors 7:41 a.m. March 17, 2014 - GlobeNewswire
AVEO Announces Timing for Conference Call to Discuss Year-End 2013 Financial Results and Provide Strategic Update for 2014 7:31 a.m. March 4, 2014 - BusinessWire - BZX
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and Commercialization of Tivozanib 6:31 a.m. Feb. 14, 2014 - BusinessWire - BZX
Catabasis Announces Appointment of Kenneth M. Bate as Independent Director 9:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
AVEO and Astellas Discontinue Phase 2 Trial of Tivozanib in Breast Cancer 7:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
AVEO Provides Update on Interim Analysis from Tivozanib Trial in Colorectal Cancer 7:50 a.m. Dec. 13, 2013 - BusinessWire
AVEO Reports Third Quarter 2013 Financial Results 7:32 a.m. Nov. 7, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 1:18 p.m. Sept. 4, 2013 - PR Newswire
AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Sept. 4, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 3:48 p.m. Aug. 28, 2013 - PR Newswire
(0)
(0)